Biologically active compounds from natural and marine natural organisms with antituberculosis, antimalarial, leishmaniasis, trypanosomiasis, anthelmintic, antibacterial, antifungal, antiprotozoal, and antiviral activities

다국어 초록 (Multilingual Abstract)

The biologically active compounds derived from different natural organisms such as animals, plants, and microorganisms like algae, fungi, bacteria and merine organisms. These natural compounds possess diverse biological activities like anthelmintic, antibacterial, antifungal, antimalarial, antiprotozoal, antituberculosis, and antiviral activities. These biological active compounds were acted by variety of molecular targets and thus may potentially contribute to several pharmacological classes. The synthesis of natural products and their analogues provides effect of structural modifications on the parent compounds which may be useful in the discovery of potential new drug molecules with different biological activities. Natural organisms have developed complex chemical defense systems by repelling or killing predators, such as insects, microorganisms, animals etc. These defense systems have the ability to produce large numbers of diverse compounds which can be used as new drugs. Thus, research on natural products for novel therapeutic agents with broad spectrum activities and will continue to provide important new drug molecules.

참고문헌 (Reference)

• 1 Miljanich GP, "Ziconotide : neuronal calcium channel blocker for treating severe chronic pain" 11 : 3029-3040, 2004
• 2 Sultanbawa MUS, "Xanthonoids of tropical plants" 36 : 1465-1506, 1980
• 3 Yang XD, "Xanthones from the stems of Securidaca inappendiculata" 58 : 1245-1249, 2001
• 4 Rath G, "Xanthones from Hypericum roeperanum" 43 : 513-520, 1996
• 5 Ignatuschenko MV, "Xanthones as antimalarial agents; studies of a possible mode of action" 409 : 67-73, 1997
• 6 World Health Organization, "What Is Malaria?"
• 7 Zancan P, "Venous and arterial thrombosis in rat models : dissociation of the antithrombotic effects of glycosaminoglycans" 15 : 45-54, 2004
• 8 Mourao PA, "Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives" 10 : 967-981, 2004
• 9 Iinuma M, "Two xanthones from root bark of Calophyllum inophyllum" 35 : 527-532, 1994
• 10 Gunasekera SP, "Two new xanthones, calozeyloxanthone and zeyloxanthonone, from Calophyllum zeylanicum(Guttiferae)" 1 : 1831-1835, 1981
• 11 Goud TV, "Two new bromotyrosine-derived metabolites from the sponge Psammaplysilla purpurea" 51 : 990-993, 2003
• 12 Liu J, "Tuberculosis : Current Treatment and New Drug Development" 5 : 331-344, 2006
• 13 Tierney D, "Tuberculosis (TB)"
• 14 Tiruviluamala P, "Tuberculosis" 23 : 403-426, 2002
• 15 Griffith KS, "Treatment of malaria in the United States : a systematic review" 297 : 2264-2277, 2007
• 16 Soto J, "Treatment of New World cutaneous leishmaniasis with miltefosine" 100suppl1 : S34-S40, 2006
• 17 World Health Organization, "The world health report 1998-Life in the 21st century : a vision for all"
• 18 Meiyu G, "The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4molecule" 59 : 127-135, 2003
• 19 Schluger NW, "The pathogenesis of tuberculosis : the first one hundred(and twenty-three)years" 32 : 251-256, 2005
• 20 Mendis K, "The neglected burden of Plasmodium vivax malaria" 64 : 97-, 2001
• 21 Tucker SJ, "The influence of alkyl pyridinium sponge toxins on membrane properties, cytotoxicity, transfection and protein expression in mammalian cells" 1614 : 171-181, 2004
• 22 Breman J, "The ears of the hippopotamus : manifestations, determinants, and estimates of the malaria burden" 64 : 1-, 2001
• 23 Masaba SC, "The antimalarial activity of Vernonia amygdalina Del(Compositae)" 94 : 694-695, 2000
• 24 Lakshmi V, "The antifilarial activity of a marine red alga, Botryocladia leptopoda, against experimental infections with animal and human filariae" 93 : 468-474, 2004
• 25 Sandsdalen E, "The antibacterial effect of a polyhydroxylated fucophlorethol from the marine brown alga, Fucus vesiculosus" 19 : 777-782, 2003
• 26 World Health Organization, "The Promotion and development of traditional medicine"
• 27 Coker HAB, "The Malaria. Scourge. Concepts in Disease Management" 32 : 19-47, 2000
• 28 Ekthawatchai S, "Synthetic and naturally occurring antimalarials" 36 : 1599-1605, 1999
• 29 Helesbeux JJ, "Synthesis of 2-hydroxy-3-methylbut-3-enyl substituted coumarins and xanthones as natural products. Application of the Schenck ene reaction of singlet oxygen with ortho-prenylphenol precursors" 60 : 2293-2300, 2004
• 30 Miao B, "Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome(AIDS)drug candidate, targeting CD4 in lymphocytes" 68 : 641-649, 2004
• 31 Lee EH, "Structureactivity relationship of lysophosphatidylcholines in HL-60human leukemia cells" 25 : 1521-1524, 2004
• 32 Iwasa K, "Structure-activity relationships of quaternary protoberberine alkaloids having an antimalarial activity" 34 : 1077-1083, 1999
• 33 Kaneko M, "Structure of a New Neuritogenic-Active Ganglioside from the Sea Cucumber Stichopus japonicus" 2003 : 1004-1008, 2003
• 34 Yang SW, "Structure elucidation of a new antifungal sterol sulfate, Sch 575867, from a deep-water marine sponge(Family : Astroscleridae)" 56 : 186-189, 2003
• 35 Edwards DJ, "Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula" 11 : 817-833, 2004
• 36 Proksch P, "Sponges (Porifera)" Springer-Verlag 117-142, 2003
• 37 Williams DE, "Spirastrellolide A: revised structure, progress toward the relative configuration, and inhibition of protein phosphatase 2A" 6 : 2607-2610, 2004
• 38 Nika K, "Specific recognition of immune cytokines by sulphated polysaccharides from marine algae" 38 : 257-264, 2003
• 39 Sudarslal S, "Sodium channel modulating activity in a deltaconotoxin from an Indian marine snail" 553 : 209-212, 2003
• 40 Somoskovi A, "Sequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications : Identification of a speciesspecific pncA mutation in"Mycobacterium canettii"and the reliable and rapid predictor of pyrazinamide resistance" 45 : 595-599, 2007
• 41 Gessler MC, "Screening Tanzanian medicinal plants for antimalarial activity" 56 : 65-77, 1994
• 42 Takada K, "Schulzeines A-C, new alpha-glucosidase inhibitors from the marine sponge Penares schulzei" 126 : 187-193, 2004
• 43 Tsang CK, "Sargaquinoic acid supports the survival of neuronal PC12D cells in a nerve growth factor-independent manner" 488 : 11-18, 2004
• 44 Kamei Y, "Sargaquinoic acid promotes neurite outgrowth via protein kinase A and MAP kinases-mediated signaling pathways in PC12D cells" 21 : 255-262, 2003
• 45 Jacob MR, "Reversal of fluconazole resistance in multidrug efflux-resistant fungi by the Dysidea arenaria sponge sterol 9alpha, 11alpha-epoxycholest-7-ene-3beta, 5alpha, 6alpha, 19-tetrol 6-acetate" 66 : 1618-1622, 2003
• 46 World Health Organization, "Report of the WHO Informal Consultation on the Evaluation and Testing of Insecticides. CTD/WHOPES/IC. Control of Tropical Diseases Division" World Health Organization 69-, 1996
• 47 World Health Organization, "Report of the Scientific Working Group on Chagas Disease Buenos Aires, Argentina 17-20 April 2005" WHO 2005
• 48 Masuno MN, "Relationship between body mass index and anti-hypertensive efficacy of doxazosin according to a survey of Japanese patients" 2 : 176-184, 2004
• 49 Boulahbal F, "Reichman and Hershfield's Tuberculosis" nforma Healthcare USA Inc 29-47, 2006
• 50 Matsubara K, "Recent advances in marine algal anticoagulants" 2 : 13-19, 2004
• 51 Aoki S, "Pyridoacridine alkaloids inducing neuronal differentiation in a neuroblastoma cell line, from marine sponge Biemna fortis" 11 : 1969-1973, 2003
• 52 Pascual I, "Purification of a specific inhibitor of pyroglutamyl aminopeptidase II from the marine annelide Hermodice carunculata. in vivo effects in rodent brain" 36 : 138-152, 2004
• 53 Ovchinnikova TV, "Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina" 577 : 209-214, 2004
• 54 Verbitski SM, "Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity" 47 : 2062-2070, 2004
• 55 Erdogan-Orhan I, "Polyprenyl-hydroquinones and-furans from three marine sponges inhibit the cell cycle regulating phosphatase CDC25A" 18 : 1-9, 2004
• 56 Tincu JA, "Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes" 278 : 13546-13553, 2003
• 57 Pimentel SM, "Platelet aggregation inhibitors from Philippine marine invertebrate samples screened in a new microplate assay" 5 : 395-400, 2003
• 58 Pan W, "Perinerin, a novel antimicrobial peptide purified from the clamworm Perinereis aibuhitensis grube and its partial characterization" 135 : 297-304, 2004
• 59 Yamada T, "Peribysins A-D, potent cell-adhesion inhibitors from a sea harederived culture of Periconia species" 2 : 2131-2135, 2004
• 60 Nakao Y, "Penasulfate A, a new alpha-glucosidase inhibitor from a marine sponge Penares sp" 67 : 1346-1350, 2004
• 61 Tsukamoto S, "Parguerol and isoparguerol isolated from the Sea Hare, Aplysia kurodai, induce neurite outgrowth in PC-12 cells" 2 : 170-175, 2004
• 62 Minami H, "Novel xanthones with superoxide scavenging activity from Garcinia subelliptica" 43 : 347-349, 1995
• 63 Sakai R, "Novel betaines from a micronesian sponge Dysidea herbacea" 69 : 1180-1185, 2004
• 64 Go ML, "Novel antiplasmodial agents" 23 : 456-487, 2003
• 65 Patrzykat A, "Novel antimicrobial peptides derived from flatfish genes" 47 : 2464-2470, 2003
• 66 Keyzers RA, "Novel antiinflammatory Spongian Diterpenes from the New Zealand Marine Sponge Chelonaplysilla violacea" 2004 : 419-425, 2004
• 67 Kehraus S, "Novel amino acid derived naturalproducts from the ascidian Atriolum robustum : identification and pharmacological characterization of a unique adenosine derivative" 47 : 2243-2255, 2004
• 68 Morel C, "New xanthones from Calophyllum caledonicum" 63 : 1471-1474, 2000
• 69 Chill L, "New sesterterpenes from Madagascan Lendenfeldia sponges" 60 : 10619-10626, 2004
• 70 Mukku VJ, "New sesquiterpene quinols from a Micronesian sponge, Aka sp" 66 : 686-689, 2003
• 71 Rodríguez II, "New pseudopterosin and seco-pseudopterosin diterpene glycosides from two Colombian isolates of Pseudopterogorgia elisabethae and their diverse biological activities" 67 : 1672-1680, 2004
• 72 Tsukamoto S, "New polyhydroxy sterols : proteasome inhibitors from a marine sponge Acanthodendrilla sp" 66 : 1181-1185, 2003
• 73 Satitpatipan V, "New nitrogenous Germacranes from a Thai marine sponge, Axinyssa n. sp" 67 : 503-505, 2004
• 74 Rao KV, "New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge" 66 : 823-828, 2003
• 75 Dmitrenok AS, "New lipids from the soft corals of the Andaman Islands" 52 : 1868-1872, 2003
• 76 Krishnaiah P, "New lamellarin alkaloids from the Indian ascidian Didemnum obscurum and their antioxidant properties" 67 : 1168-1171, 2004
• 77 Ata A, "New antibacterial diterpenes from Pseudopterogorgia elisabethae" 87 : 1090-1098, 2004
• 78 Morel C, "New and antifungal xanthones from Calophyllum caledonicum" 68 : 41-44, 2002
• 79 World Health Organization, "New Plan to Contain DrugResistant TB" WHO
• 80 Hassan W, "New Imidazole Alkaloids from the Indonesian Sponge Leucetta chagosensis" 67 : 817-822, 2004
• 81 Capon RJ, "Nematocidal thiocyanatins from a southern Australian marine sponge, Oceanapia sp" 67 : 1277-1282, 2004
• 82 Oku N, "Neamphamide A, a new HIV-inhibitory depsipeptide from the Papua New Guinea marine sponge Neamphius huxleyi" 67 : 1407-1411, 2004
• 83 Jung M, "Naturally occurring peroxides with biological activities" 3 : 159-165, 2003
• 84 Laurent D, "Natural-product diversity of the New Caledonian marine ecosystem compared to other ecosystems : a pharmacologically oriented view" 1 : 539-594, 2004
• 85 Tziveleka LA, "Natural products with antiHIV activity from marine organisms" 3 : 1512-1535, 2003
• 86 Butler MS, "Natural products to drugs : natural product derived compounds in clinical trials" 22 : 162-195, 2005
• 87 Salem MM, "Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis" 13 : 2571-2598, 2006
• 88 Newman DJ, "Natural products as sources of new drugs over the period 1981-2002" 66 : 1022-1037, 2003
• 89 Newman DJ, "Natural products as sources of new drugs over the last 25 years" 70 : 461-477, 2007
• 90 Copp BR, "Natural product growth inhibitors of Mycobacterium tuberculosis" 24 : 278-297, 2007
• 91 Potterat O, "Natural Products in Drug Discovery-Concepts and Approaches for Tracking Bioactivity" 10 : 899-920, 2006
• 92 Endo T, "Nagelamides A-H, new dimeric bromopyrrole alkaloids from marine sponge Agelas species" 67 : 1262-1267, 2004
• 93 Smith I, "Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence" 16 : 463-496, 2003
• 94 Lucas R, "Modulatory effect of bolinaquinone, a marine sesquiterpenoid, on acute and chronic inflammatory processes" 304 : 1172-1180, 2003
• 95 Bernan VS, "Mining marine microorganisms as a source of new antimicrobials and antifungals" 3 : 181-195, 2004
• 96 Luque-Ortega JR, "Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes" 51 : 1327-1332, 2007
• 97 Williams DE, "Meroterpenoid MAPKAP (MK2) inhibitors isolated from the indonesian marine sponge Acanthodendrilla sp" 67 : 2127-2129, 2004
• 98 Gompel M, "Meridianins, a new family of protein kinase inhibitors isolated from the ascidian Aplidium meridianum" 14 : 1703-1707, 2004
• 99 Wang CY, "Melophlins C-O, thirteen novel tetramic acids from the marine sponge Melophlus sarassinorum" 66 : 51-56, 2003
• 100 Nishimura S, "Massadine, a novel geranylgeranyltransferase type I inhibitor from the marine sponge Stylissa aff. massa" 5 : 2255-2257, 2003
• 101 Mayer AMS, "Marine pharmacology in 2003-4 : marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, antiinflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action" 145 : 553-581, 2007
• 102 Mayer AMS, "Marine pharmacology in 2001-2002 : Marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action" 140 : 265-286, 2004
• 103 Mayer AMS, "Marine pharmacology in 2000:marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action" 6 : 37-52, 2004
• 104 Mayer AMS, "Marine pharmacology in 1999 : compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action" 132 : 315-339, 2002
• 105 Mayer AMS, "Marine pharmacology in 1998 : Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, anthelmintic, antiplatelet, antiprotozoal, and antiviral activities; with actions on the cardiovascular, endocrine, immune, and nervous systems; and other miscellaneous mechanisms of action" 42 : 62-69, 2000
• 106 Frenz JL, "Marine natural products as therapeutic agents: Part 2" 14 : 17-33, 2004
• 107 Takamatsu S, "Marine natural products as novel antioxidant prototypes" 66 : 605-608, 2003
• 108 Gochfeld DJ, "Marine natural products as lead anti-HIV agents" 3 : 401-424, 2003
• 109 Donia M, "Marine natural products and their potential applications as anti-infective agents" 3 : 338-348, 2003
• 110 Schmitz FJ, "Marine Biotechnology, Pharmaceutical and Bioactive Natural Products, vol 1" Plenum Press 197-308, 1993
• 111 Namikoshi M, "Manoalide derivatives from a marine sponge Luffariella sp. collected in Palau" 70 : 152-158, 2004
• 112 WHO, "Malaria"
• 113 Isnansetyo A, "MC21-A, a Bactericidal Antibiotic Produced by a New Marine Bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against Methicillin-Resistant Staphylococcus aureus" 47 : 480-488, 2003
• 114 Cho SH, "Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis" 51 : 1380-1385, 2007
• 115 Qi J, "Linckosides C-E, three new neuritogenic steroid glycosides from the Okinawan starfish Linckia laevigata" 12 : 4259-4265, 2004
• 116 Desjeux P, "Leishmania/HIV co-infections:epidemiology in Europe" 97 : 3-15, 2003
• 117 Bugni TS, "Kalihinols from two Acanthella cavernosa sponges : Inhibitors of bacterial folate biosynthesis" 60 : 6981-6988, 2004
• 118 Sakai R, "Isolations of N-methyl-D-aspartic acid-type glutamate receptor ligands from Micronesian sponges" 66 : 784-787, 2003
• 119 Yoo HD, "Isoarenarol, a new protein kinase inhibitor from the marine sponge Dysidea arenaria" 41 : 223-225, 2003
• 120 McClelland D, "Irreversible and reversible pore formation by polymeric alkylpyridinium salts(poly-APS)from the sponge Reniera sarai" 139 : 1399-1408, 2003
• 121 Cragg GM, "Introduction. AnticancerAgents from Natural Products" Taylor & Francis 1-3, 2005
• 122 Staats PS, "Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS : a randomized controlled trial" 291 : 63-70, 2004
• 123 Sharpe IA, "Inhibition of the norepinephrine transporter by the venom peptide chi-MrIA. Site of action, Na+dependence, and structure-activity relationship" 278 : 40317-40323, 2003
• 124 Posadas I, "Inhibition of the NF-kappaB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M" 65 : 887-895, 2003
• 125 Perez M, "Inhibition by Aplidine of the aggregation of the prion peptide PrP 106-126 into betasheet fibrils" 1639 : 133-139, 2003
• 126 Nicholas GM, "Inhibition and kinetics of mycobacterium tuberculosis and mycobacterium smegmatis mycothiol-Sconjugate amidase by natural product inhibitors" 11 : 601-608, 2003
• 127 De Oliveira JH, "Ingenamine G and cyclostellettamines G-I, K, and L from the new Brazilian species of marine sponge Pachychalina sp" 67 : 1685-1689, 2004
• 128 Kobayashi M, "Indonesian medicinal plants. XXI. Inhibitors of Na+/H+exchanger from the bark of Erythrina variegate and the roots of Maclura cochinchinensis" 45 : 1615-1619, 1997
• 129 Fotie J, "In-vivo antimalarial activity of some oxygenated xanthones" 97 : 683-688, 2003
• 130 Tran QL, "In vitro antiplasmodial activity of antimalarial medicinal plants used in Vietnamese traditional medicine" 86 : 249-252, 2003
• 131 Hong S, "In vitro anti-inflammatory and pro-aggregative effects of a lipid compound, petrocortyne A, from marine sponges" 368 : 448-456, 2003
• 132 Soon Sung Lim, "In vitro Antimalarial Activity of Flavonoids and Chalcones" 대한화학회 28 (28): 2495-2497, 2007
• 133 Nakao Y, "Identification of Renieramycin A as an Antileishmanial Substance in a Marine Sponge Neopetrosia sp" 2 : 55-62, 2004
• 134 Trager W, "Human malaria parasites in continuous culture" 193 : 673-677, 1976
• 135 Boelaert M, "How better drugs could change kala-azar control. Lessons from a costeffectiveness analysis" 7 : 955-959, 2002
• 136 Rodríguez II, "Homopseudopteroxazole, a new antimycobacterial diterpene alkaloid from Pseudopterogorgia elisabethae" 66 : 855-857, 2003
• 137 Patrzykat A, "Gone gene fishing : how to catch novel marine antimicrobials" 21 : 362-369, 2003
• 138 Monti MC, "Further insights on the structural aspects of PLA(2)inhibition by gamma-hydroxybutenolide-containing natural products : a comparative study on petrosaspongiolides M-R" 12 : 1467-1474, 2004
• 139 Ankisetty S, "Further Membranolide Diterpenes from the Antarctic Sponge Dendrilla membranosa" 67 : 1172-1174, 2004
• 140 Haynes RK, "From artemisinin to new artemisinin antimalarials : biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements" 6 : 509-537, 2006
• 141 Oger JM, "First 2-hydroxy-3-methylbut-3-enyl substituted xanthones isolated from plants : structure elucidation, synthesis and antifungal activity" 17 : 195-199, 2003
• 142 Lukes J, "Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy" 104 : 9375-9380, 2007
• 143 Villar RM, "Evaluation of the effects of several zoanthamine-type alkaloids on the aggregation of human platelets" 11 : 2301-2306, 2003
• 144 Schupp P, "Eudistomins W and X, two new beta-carbolines from the micronesian tunicate Eudistoma sp" 66 : 272-275, 2003
• 145 Donaghy L, "Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen(HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis" 147 : 236-240, 2007
• 146 Fennell BJ, "Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum" 51 : 833-841, 2003
• 147 Vetvicka V, "Effects of marine beta-1, 3 glucan on immune reactions" 4 : 721-730, 2004
• 148 Ohgami K, "Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo" 44 : 2694-2701, 2003
• 149 Livett BG, "Drugs from the sea : conopeptides as potential therapeutics" 11 : 1715-1723, 2004
• 150 Chin YW, "Drug discovery from natural sources" 8 : E239-E253, 2006
• 151 Proksch P, "Detection of pharmacologically active natural products using ecology : selected examples from indopacific marine invertebrates and sponge-derived fungi" 75 : 343-352, 2003
• 152 Portela C, "Definition of an electronic profile of compounds with inhibitory activity against hematin aggregation in malaria parasite" 12 : 3313-3321, 2004
• 153 Kuo YH, "Cytotoxic constituents from the stems of Diospyros maritima" 63 : 363-365, 1997
• 154 Gu QJ, "Cytotoxic and Antimicrobial Constituents of the Bark of Diospyros maritima Collected in Two Geographical Locations in Indonesia" 67 : 1156-1161, 2004
• 155 Lucas R, "Cycloamphilectenes, a new type of potent marine diterpenes : inhibition of nitric oxide production in murine macrophages" 72 : 2543-2552, 2003
• 156 Golenser J, "Current perspectives on the mechanism of action of artemisinins" 36 : 1427-1441, 2006
• 157 Uchida T, "Crystal structure of the hemolytic lectin CEL-III isolated from the marine invertebrate Cucumaria echinata : implications of domain structure for its membrane pore-formation mechanism" 279 : 37133-37141, 2004
• 158 Chang L, "Crambescidin 826 and dehydrocrambine A: New polycyclic guanidine alkaloids from the marine sponge Monanchora sp. That inhibit HIV-1 fusion" 66 : 1490-1494, 2003
• 159 Grant MA, "Conotoxins and Structural Biology: A Prospective Paradigm for Drug Discovery" 5 : 235-248, 2004
• 160 Akilov OE, "Clinical manifestations and classification of Old World cutaneous leishmaniasis" 46 : 132-142, 2007
• 161 Keyzers RA, "Clathriol B, a new 14beta marine sterol from the New Zealand sponge Clathria lissosclera" 56 : 279-282, 2003
• 162 Fernandez-Busquets X, "Circular proteoglycans from sponges : first members of the spongican family" 60 : 88-112, 2003
• 163 Paterson I, "Chemistry. The renaissance of natural products as drug candidates" 310 : 451-453, 2005
• 164 Tsai MC, "Characterization of the tuberculous granuloma in murine and human lungs : cellular composition and relative tissue oxygen tension" 8 : 218-232, 2006
• 165 "Chagas Disease Fact Sheet"
• 166 Tosuji H, "Calyculin A causes the activation of histone H1 kinase and condensation of chromosomes in unfertilized sea urchin eggs independently of the maturationpromoting factor" 135 : 415-424, 2003
• 167 Fujita M, "Callysponginol sulfate A, an MT1-MMP inhibitor isolated from the marine sponge Callyspongia truncata" 66 : 569-571, 2003
• 168 Trevisi L, "Callipeltin A : sodium ionophore effect and tension development in vascular smooth muscle" 68 : 1331-1338, 2004
• 169 Posadas I, "Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-alpha by inhibiting nuclear factor-kappa B activation" 138 : 1571-1579, 2003
• 170 Buss AD, "Burger's Medicinal Chemistry and Drug Discovery, Volume 1: Principals and Practice" Wiley 983-1034, 1995
• 171 Ospina CA, "Briarellins J-P and polyanthellin A : new eunicellin-based diterpenes from the gorgonian coral Briareum polyanthes and their antimalarial activity" 66 : 357-363, 2003
• 172 Rezwan M, "Breaking down the wall : fractionation of mycobacteria" 68 : 32-39, 2007
• 173 Kouam TNM, "Bipendensin, an unusual phenolic acetal from Afzelia bipendensis" 3 : 299-303, 1993
• 174 Zhang W, "Biopotentials of marine sponges from China oceans: past and future" 20 : 413-419, 2003
• 175 Aneiros A, "Bioactive peptides from marine sources : pharmacological properties and isolation procedures" 803 : 41-53, 2004
• 176 Marrero J, "Bielschowskysin, a gorgonianderived biologically active diterpene with an unprecedented carbon skeleton" 6 : 1661-1664, 2004
• 177 Tsukamoto S, "Aspermytin A : a new neurotrophic polyketide isolated from a marine-derived fungus of the genus Aspergillus" 14 : 417-420, 2004
• 178 Haynes RK, "Artemisone--a highly active antimalarial drug of the artemisinin class" 45 : 2082-2088, 2006
• 179 ZhuW, "Antiviral property and mode of action of a sulphated polysaccharide from Sargassum patens against herpes simplex virus type 2" 24 : 279-283, 2004
• 180 Gustafson KR, "Antiviral marine natural products" 3 : 233-249, 2004
• 181 Yim JH, "Antiviral effects of sulfated exopolysaccharide from the marine microalga Gyrodinium impudicum strain KG03" 6 : 17-25, 2004
• 182 Pereira HS, "Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1(HIV-1)" 64 : 69-76, 2004
• 183 Janin YL, "Antituberculosis drugs : ten years of research" 15 : 2479-2513, 2007
• 184 Wonganuchitmeta SN, "Antitubercular sesterterpenes from the Thai sponge Brachiaster sp" 67 : 1767-1770, 2004
• 185 Melo FR, "Antithrombinmediated anticoagulant activity of sulfated polysaccharides : different mechanisms for heparin and sulfated galactans" 279 : 20824-20835, 2004
• 186 Roch P, "Antiprotozoan and Antiviral Activities of Non-cytotoxic Truncated and Variant Analogues of Mussel Defensin" 1 : 167-174, 2004
• 187 Wei X, "Antiplasmodial cembradiene diterpenoids from a Southwestern Caribbean gorgonian octocoral of the genus Eunicea" 60 : 11813-11819, 2004
• 188 Hay A-E, "Antioxidant xanthones from Garcinia vieillardii" 67 : 707-709, 2004
• 189 Ya Hong Jiang, "Antioxidant Activity of (8E,13Z,20Z)-Strobilinin(7E,13Z,20Z)-Felixinin from a Marine Sponge Psammocinia sp" 한국생약학회 10 (10): 272-276, 2004
• 190 Copp BR, "Antimycobacterial natural products" 20 : 535-557, 2003
• 191 Rijal S, "Antimonial treatment of visceral leishmaniasis : are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?" 9 : 529-535, 2007
• 192 Tincu JA, "Antimicrobial peptides from marine invertebrates. Antimicrob" 48 : 3645-3654, 2004
• 193 Lippert H, "Antimicrobial activity in sub-Arctic marine invertebrates" 26 : 591-600, 2003
• 194 Rifai S, "Antimicrobial Activity of Untenospongin B, a Metabolite from the Marine Sponge Hippospongia communis collected from the Atlantic Coast of Morocco" 2 : 147-153, 2004
• 195 Savoia D, "Antimicrob. Antimicrobial activity of euplotin C, the sesquiterpene taxonomic marker from the marine ciliate Euplotes crassus" 48 : 3828-3833, 2004
• 196 Likhitwitayawuid K, "Antimalarials from Stephania venosa, Prismatomeris sessiliflora, Diospyros montana and Murraya siamensis" 65 : 754-756, 1999
• 197 Opsenica D, "Antimalarial, antimycobacterial and antiproliferative activity of phenyl substituted mixed tetraoxanes" 68 : 291-302, 2003
• 198 Hay AE, "Antimalarial xanthones from Calophyllum caledonicum and Garcinia vieillardii" 75 : 3077-3085, 2004
• 199 Theerachayanan T, "Antimalarial and antimycobacterial activities of dimeric naphthoquinones from Diospyros glandulosa and Diospyros rhodocalyx" 6 : 253-259, 2007
• 200 Hay A-E, "Antifungal chromans inhibiting the mitochondrial respiratory chain of pea seeds and new xanthones from Calophyllum caledonicum" 69 : 1130-1135, 2003
• 201 Xu N, "Antibacterial bromophenols from the marine red alga Rhodomela confervoides" 62 : 1221-1224, 2003
• 202 Pettit RK, "Antibacterial activity of the marine sponge constituent cribrostatin 6" 53 : 61-65, 2004
• 203 Oyewole IO, "Anti-malarial and repellent activities of Tithonia diversifolia (Hemsl.) leaf extracts" 2 : 171-175, 2008
• 204 Keyzers RA, "Anti-inflammatory metabolites from marine sponges" 34 : 355-365, 2005
• 205 Luescher-Mattli M, "Anti-infective Agents" 2 : 219-225, 2003
• 206 Maskey RP, "Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycete and their absolute stereochemistry" 57 : 771-779, 2004
• 207 Molinski TF, "Anti-Infect. Agents" 3 : 197-220, 2004
• 208 Goud TV, "Anti-HIV active petrosins from the marine sponge Petrosia similis" 26 : 1498-1501, 2003
• 209 Willert EK, "Allosteric regulation of an essential trypanosome polyamine biosynthetic enzyme by a catalytically dead homolog" 104 : 8275-8280, 2007
• 210 Fujita M, "Ageladine A: an antiangiogenic matrixmetalloproteinase inhibitor from the marine sponge Agelas nakamurai" 125 : 15700-15701, 2003
• 211 Hirono M, "Acylspermidine derivatives isolated from a soft coral, Sinularia sp, inhibit plant vacuolar H(+)-pyrophosphatase" 133 : 811-816, 2003
• 212 Hu J, "Acidic oligosaccharide sugar chain, a marine-derived acidic oligosaccharide, inhibits the cytotoxicity and aggregation of amyloid beta protein" 95 : 248-255, 2004
• 213 Iijima R, "A novel antimicrobial peptide from the sea hare Dolabella auricularia" 27 : 305-311, 2003
• 214 Yang SW, "A new sterol sulfate, Sch 572423, from a marine sponge, Topsentia sp" 13 : 1791-1794, 2003
• 215 Yang SW, "A new sesterterpene, Sch 599473, from a marine sponge, Ircinia sp" 56 : 783-786, 2003
• 216 Yang SW, "A new bicyclic guanidine alkaloid, Sch 575948, from a marine sponge, Ptilocaulis spiculifer" 56 : 970-972, 2003
• 217 Ito C, "A Novel Dibenzofuran and Two New Xanthones form Calophyllum panciflorum" 44 : 441-443, 1996
• 218 Radhika P, "5Alpha-reductase inhibition activity of steroids isolated from marine soft corals" 69 : 439-444, 2004
• 219 Kossuga MH, "(2S, 3R)-2-aminododecan-3-ol, a new antifungal agent from the ascidian Clavelina oblonga" 67 : 1879-1881, 2004